radiotherapy. In all 11 patients who underwent surgery before radiotherapy, an increase in PRL was seen after radiotherapy. In the 21 patients followed for 10\p=n-\12years, the peak PRL value occurred 1\p=n-\16 years after radiotherapy. After this, a progressive reduction of PRL to normal was seen. Normal levels were reached 4 to 10 years after radiotherapy. No Elevated circulating prolactin is often observed in patients with acromegaly (1) (2) (3) (4) (5) . Several mechan¬ isms may induce this abnormality. The adenoma may contain either separate GH and PRL secreting cells (6) (7) (8) , or a single cell line producing both GH and PRL (9, 10) . More rarely, two distinct adenomas may be observed in the pituitary (11) . The con¬ comitant secretion of both hormones may account for the positive correlation between basal GH and PRL reported by some authors (12) . Hyperprolactinaemia may also be secondary to hypothalamic-pituitary disconnection caused by pressure of the tu¬ mour mass on the pituitary stalk, with subsequent reduction of dopaminergic inhibition of PRL se¬ cretion (13, 14) . Finally, hyperprolactinaemia has been documented following radiotherapy (12, 15, 16) and this has been claimed to be characteristic of patients who were normoprolactinaemic before treatment (12) .
To date, two series of patients totalling 85 have been studied (12, 16 Fig. 3 . The dashed line portrays the upper limit of normal for PRL. lar to reports from other authors (3) (4) (5) . In contrast to other series, however (2, 12) , elevated PRL levels were more common and significantly higher in male than in female patients, but no correlation between basal PRL and GH was found. This dis¬ crepancy may be explained by a different pre¬ valence of hyperprolactinaemia due either to mixed GH and PRL secreting tumours or stalk compression. Higher PRL levels are observed in the presence of a PRL secreting adenoma, while only mild hyperprolactinaemia results from stalk compression by a non-prolactin secreting tumour (22) . Our 
